AC Immune SA is headquartered in Lausanne, Switzerland, where its primary corporate offices, executive management teams, and central research laboratories are situated. From this operational base in the Swiss biotech hub, the company coordinates its extensive international clinical development pipeline, manages collaborative agreements with major global pharmaceutical enterprises, and oversees regulatory compliance across its precision medicine programs targeting neurodegenerative disorders. The location provides strategic access to top-tier European scientific talent, research institutions, and specialized funding networks dedicated to advancing innovative therapeutic treatments.